Adalimumab
- Product NDC
- 61314-391
- 11-digit product format
- 613140391
- Labeler code
- 61314
- Product ID
- 61314-391_ae54abc4-e9c5-4c5a-8fa7-968e5ad72050
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- adalimumab-adaz
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- Sandoz Inc
- Application
- BLA761071
- Marketing category
- BLA
- Marketing start
- 2025-03-26
- Substance
- ADALIMUMAB
- Active strength
- 10 mg/.1mL
- Pharmacologic classes
- Antibodies, Monoclonal [CS], Tumor Necrosis Factor Blocker [EPC], Tumor Necrosis Factor Receptor Blocking Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Adalimumab
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ADALIMUMAB | 10 mg/.1mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | FYS6T7F842 |
| Rxcui | 2641644, 2641653, 2641655, 2641660, 2641662 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 58819a18-327d-463b-9e5e-26cc1dd9870d | Product name | 1 | 20230313 |
| c1c5a070-0e2e-43dd-af9c-a21585200342 | Product name | 1 | 20230104 |
| 2a463079-cd68-4798-a3d6-55c4c8578d57 | Product name | 1 | 20220728 |
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| 652f8f6b-479d-477c-848a-374d5b0145b7 | Product name | 2 | 20151203 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 61314-391-64 | Adalimumab | 0.1 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 0.1 | 15 | |
| 61314-391-64 | Adalimumab | 2 in 1 CARTON | INJECTION, SOLUTION | 2 | 15 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 2641644 | adalimumab-adaz 10 MG in 0.1 ML Prefilled Syringe | PSN | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641653 | adalimumab-adaz 20 MG in 0.2 ML Prefilled Syringe | PSN | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641655 | adalimumab-adaz 40 MG in 0.4 ML Auto-Injector | PSN | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641660 | adalimumab-adaz 40 MG in 0.4 ML Prefilled Syringe | PSN | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641662 | adalimumab-adaz 80 MG in 0.8 ML Auto-Injector | PSN | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641644 | 0.1 ML adalimumab-adaz 100 MG/ML Prefilled Syringe | SCD | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641653 | 0.2 ML adalimumab-adaz 100 MG/ML Prefilled Syringe | SCD | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641655 | 0.4 ML adalimumab-adaz 100 MG/ML Auto-Injector | SCD | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641660 | 0.4 ML adalimumab-adaz 100 MG/ML Prefilled Syringe | SCD | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641662 | 0.8 ML adalimumab-adaz 100 MG/ML Auto-Injector | SCD | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641644 | adalimumab-adaz 10 MG per 0.1 ML Prefilled Syringe | SY | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641653 | adalimumab-adaz 20 MG per 0.2 ML Prefilled Syringe | SY | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641655 | adalimumab-adaz 40 MG per 0.4 ML Auto-Injector | SY | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641660 | adalimumab-adaz 40 MG per 0.4 ML Prefilled Syringe | SY | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
| 2641662 | adalimumab-adaz 80 MG per 0.8 ML Auto-Injector | SY | 3468792f-63ef-4916-8ed1-8214f327d9dd | 15 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 61314-391-64 | 61314039164 | 2 SYRINGE, GLASS in 1 CARTON (61314-391-64) / .1 mL in 1 SYRINGE, GLASS | 2025-03-26 | No | No | Current |